Inicio › Linfoma de Burkitt › Delaware
Ensayos clínicos de Linfoma de Burkitt en Delaware
7 estudios sobre Linfoma de Burkitt buscan participantes en Delaware.
Texto oficial del estudio (inglés)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Alfred I duPont Hospital for Children, Wilmington
ReclutandoFase 2
366 Days – 46 Years · Todos los sexos · Actualizado el 2 oct 2026 · NCT06124157Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT03739814Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Alfred I duPont Hospital for Children, Wilmington
ReclutandoFase 2
365 Days · Todos los sexos · Actualizado el 25 sept 2026 · NCT06317662A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Alfred I duPont Hospital for Children, Wilmington
ReclutandoFase 2
Edades de 1 a 30 · Todos los sexos · Actualizado el 1 sept 2026 · NCT04546399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Alfred I duPont Hospital for Children, Wilmington
ReclutandoFase 3
365 Days – 25 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT03959085Study of SGR-1505 in Mature B-Cell Neoplasms
- Christiana Care Hospital - Helen F Graham Cancer Center, Newark
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 feb 2026 · NCT05544019The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington
ReclutandoFase 2
Edades de 1 a 25 · Todos los sexos · Actualizado el 4 may 2025 · NCT03509961De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.